Gunnar Fernström

Investment Director of InnovationsKapital, which he joined in 1998. Gunnar has built up InnovationsKapital’s presence in the Healthcare & Life Science sector. He has been responsible for InnovationsKapital’s investments in for example Carmen Systems (acq. by Boeing Corporation), Cellartis (acq by Cellectis S.A.) and BioInvent (IPO on OMX). He has done 18 investments and is currently representing InnKap on the boards of 21 Grams, Besedo, Medius, PBM, Scienta Scientific and Upfront.

Prior to joining InnovationsKapital, Gunnar held various positions within SCA Mölnlycke including Managing Director of the Health Care Division, Managing Director of the Absorbent Product Supply Division, and Executive Vice President of the SCA Mölnlycke Group. He has a MSc in Chemical Engineering and an IMD Geneva in International Marketing

Gunnar Fernström is the Investments Director at Innovations Kapital, based in Europe. With a background in Financial Services, Gunnar Fernström has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.